240 related articles for article (PubMed ID: 15311075)
21. The nature and extent of urinary morbidity in relation to prostate brachytherapy urethral dosimetry.
Neill M; Studer G; Le L; McLean M; Yeung I; Pond G; Crook JM
Brachytherapy; 2007; 6(3):173-9. PubMed ID: 17681239
[TBL] [Abstract][Full Text] [Related]
22. [Acute adverse effects of high dose brachytherapy in combination with external radiotherapy in localized prostate cancer].
Soumarová R; Homola L; Stursa M; Perková H
Cas Lek Cesk; 2006; 145(1):43-9. PubMed ID: 16468241
[TBL] [Abstract][Full Text] [Related]
23. Severity categories of the International Prostate Symptom Score before, and urinary morbidity after, permanent prostate brachytherapy.
Gutman S; Merrick GS; Butler WM; Wallner KE; Allen Z; Galbreath RW; Adamovich E
BJU Int; 2006 Jan; 97(1):62-8. PubMed ID: 16336330
[TBL] [Abstract][Full Text] [Related]
24. Acute toxicity of conformal high dose interstitial brachytherapy boost in prostate cancer.
Soumarová R; Homola L; Stursa M; Perková H
Neoplasma; 2006; 53(5):410-7. PubMed ID: 17013535
[TBL] [Abstract][Full Text] [Related]
25. Preimplant predictive factors of urinary retention after iodine 125 prostate brachytherapy.
Mabjeesh NJ; Chen J; Stenger A; Matzkin H
Urology; 2007 Sep; 70(3):548-53. PubMed ID: 17905113
[TBL] [Abstract][Full Text] [Related]
26. Acute urinary morbidity following I-125 prostate brachytherapy.
Ohashi T; Yorozu A; Toya K; Saito S; Momma T
Int J Clin Oncol; 2005 Aug; 10(4):262-8. PubMed ID: 16136372
[TBL] [Abstract][Full Text] [Related]
27. The need and prospect of individualized external beam radiotherapy dose escalation beyond 80 gy to treat prostate cancer: in regard to Eade et al. (Int J. Radiat. Oncol. Biol. Phys. 2007;68:682-689).
Cheung MR
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):645; author reply 645-6. PubMed ID: 18207039
[No Abstract] [Full Text] [Related]
28. Urinary side effects and complications after permanent prostate brachytherapy: the MD Anderson Cancer Center experience.
Anderson JF; Swanson DA; Levy LB; Kuban DA; Lee AK; Kudchadker R; Phan J; Bruno T; Frank SJ
Urology; 2009 Sep; 74(3):601-5. PubMed ID: 19589580
[TBL] [Abstract][Full Text] [Related]
29. Success of sildenafil for erectile dysfunction in men treated with brachytherapy or external beam radiation for prostate cancer.
Shemtov OM; Radomski SB; Crook J
Can J Urol; 2004 Dec; 11(6):2450-5. PubMed ID: 15636671
[TBL] [Abstract][Full Text] [Related]
30. Rectal complications after prostate brachytherapy.
Shah SA; Cima RR; Benoit E; Breen EL; Bleday R
Dis Colon Rectum; 2004 Sep; 47(9):1487-92. PubMed ID: 15486745
[TBL] [Abstract][Full Text] [Related]
31. Rectourethral fistula after combination radiotherapy for prostate cancer.
Marguet C; Raj GV; Brashears JH; Anscher MS; Ludwig K; Mouraviev V; Robertson CN; Polascik TJ
Urology; 2007 May; 69(5):898-901. PubMed ID: 17482930
[TBL] [Abstract][Full Text] [Related]
32. Salvage prostate brachytherapy for localized prostate cancer failure after external beam radiation therapy.
Lee HK; Adams MT; Motta J
Brachytherapy; 2008; 7(1):17-21. PubMed ID: 18201939
[TBL] [Abstract][Full Text] [Related]
33. Prostate high-dose-rate brachytherapy as salvage treatment of local failure after previous external or permanent seed irradiation for prostate cancer.
Tharp M; Hardacre M; Bennett R; Jones WT; Stuhldreher D; Vaught J
Brachytherapy; 2008; 7(3):231-6. PubMed ID: 18579446
[TBL] [Abstract][Full Text] [Related]
34. Late toxicity and biochemical recurrence after external-beam radiotherapy combined with permanent-source prostate brachytherapy: analysis of Radiation Therapy Oncology Group study 0019.
Lee WR; Bae K; Lawton C; Gillin M; Morton G; Firat S; Baikadi M; Kuettel M; Greven K; Sandler H
Cancer; 2007 Apr; 109(8):1506-12. PubMed ID: 17340591
[TBL] [Abstract][Full Text] [Related]
35. Rectal and urinary dysfunction in the TROG 03.04 RADAR trial for locally advanced prostate cancer.
Denham JW; Wilcox C; Lamb DS; Spry NA; Duchesne G; Atkinson C; Matthews J; Turner S; Kenny L; Tai KH; Gogna NK; Ebert M; Delahunt B; McElduff P; Joseph D
Radiother Oncol; 2012 Nov; 105(2):184-92. PubMed ID: 23127770
[TBL] [Abstract][Full Text] [Related]
36. Transurethral resection versus intermittent catheterization in patients with retention after combined brachytherapy/external beam radiotherapy for prostate cancer: transurethral resection.
Stone NN
J Urol; 2013 Mar; 189(3):800-1. PubMed ID: 23246854
[No Abstract] [Full Text] [Related]
37. Transurethral resection versus intermittent catheterization in patients with retention after combined brachytherapy/external beam radiotherapy for prostate cancer: intermittent catheterization.
Boone TB
J Urol; 2013 Mar; 189(3):801-2. PubMed ID: 23246852
[No Abstract] [Full Text] [Related]
38. Minimizing the number of implantation needles for prostate (125)I brachytherapy: an investigation of possibilities and implications.
Steggerda MJ; van der Poel HG; Moonen LM
Brachytherapy; 2010; 9(4):319-27. PubMed ID: 20691644
[TBL] [Abstract][Full Text] [Related]
39. Risk factors for the development of prostate brachytherapy related urethral strictures.
Merrick GS; Butler WM; Wallner KE; Galbreath RW; Anderson RL; Allen ZA; Adamovich E
J Urol; 2006 Apr; 175(4):1376-80; discussion 1381. PubMed ID: 16516001
[TBL] [Abstract][Full Text] [Related]
40. Long-term urinary sequelae following 125iodine prostate brachytherapy.
Crook J; Fleshner N; Roberts C; Pond G
J Urol; 2008 Jan; 179(1):141-5; discussion 146. PubMed ID: 17997424
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
